SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-160894
Filing Date
2013-04-18
Accepted
2013-04-18 16:47:57
Documents
3
Period of Report
2013-04-12
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d523446d8k.htm 8-K 29062
2 EX-3.2 d523446dex32.htm EX-3.2 61068
3 EX-14.1 d523446dex141.htm EX-14.1 70276
  Complete submission text file 0001193125-13-160894.txt   161648
Mailing Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540 (609) 243-0123
Celator Pharmaceuticals Inc (Filer) CIK: 0001327467 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54852 | Film No.: 13769623
SIC: 2834 Pharmaceutical Preparations